Newron Pharmaceuticals S.p.A. announced that Robert Leslie Holland has informed the Board of Directors of his intention to step down as a Non-Executive member of the Board of Directors, effective December 31, 2021. Robert Leslie Holland is a member of the company's R&D Committee. At this time, the company does not anticipate making any Non-Executive Director appointments.